ResearchMoz

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-03-15
No. Of Pages » 46

GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011 provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Aneurysmal Subarachnoid Hemorrhage (SAH). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aneurysmal Subarachnoid Hemorrhage (SAH) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Aneurysmal Subarachnoid Hemorrhage (SAH) 20
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials 24
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Actelion Ltd 26
Clinical Trial Overview of Actelion Ltd 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
National Taiwan University Hospital 27
Clinical Trial Overview of National Taiwan University Hospital 27
University of Cambridge 28
Clinical Trial Overview of University of Cambridge 28
University of Illinois 29
Clinical Trial Overview of University of Illinois 29
Oslo University Hospital Health 30
Clinical Trial Overview of Oslo University Hospital Health 30
University Hospital Mannheim 31
Clinical Trial Overview of University Hospital Mannheim 31
Soroka University Medical Center 32
Clinical Trial Overview of Soroka University Medical Center 32
Centre hospitalier de l'Universite de Montreal (CHUM) 33
Clinical Trial Overview of Centre hospitalier de l'Universite de Montreal (CHUM) 33
University of Virginia 34
Clinical Trial Overview of University of Virginia 34
University of California, Los Angeles 35
Clinical Trial Overview of University of California, Los Angeles 35
Rouen University Hospital 36
Clinical Trial Overview of Rouen University Hospital 36
Rigshospitalet 37
Clinical Trial Overview of Rigshospitalet 37
University of Miami 38
Clinical Trial Overview of University of Miami 38
Vanderbilt University 39
Clinical Trial Overview of Vanderbilt University 39
University of Illinois 40
Clinical Trial Overview of University of Illinois 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Charite University 42
Clinical Trial Overview of Charite University 42

Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About GlobalData 45
Contact Us 45
Disclaimer 45
Source 45

List of Tables


Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 11
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 18
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Terminated Clinical Trials, 2011* 20
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 25
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2011* 26
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 27
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2011* 28
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2011* 29
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital Health, 2011* 30
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Mannheim, 2011* 31
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2011* 32
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre hospitalier de l'Universite de Montreal (CHUM), 2011* 33
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2011* 34
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011* 35
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2011* 36
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2011* 37
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2011* 38
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011* 39
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2011* 40
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011* 41
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011* 42

List of Figures


Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011* 15
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 18
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 25
GlobalData Methodology 44

Upcoming Reports:

Bio-services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Bio-services involve preclinical and clinical researches done by following the standards laid down by regulatory bodies. Clinical research organizations (CRO) segment their researches by contracts, manufacturing, and clinical trials. A clinical trial is a time consuming process, and specifies testing of the new drugs on specific people or for particular diseases. CRO can be divided into captive and independent. The former involves developing and testing of developed drug in-house whereas the latter involves testing of drugs developed by some other organization. ...
Noninvasive Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Prenatal diagnostics procedure is implemented to determine the health of the fetus in the mother’s womb. This method is generally used for diagnosing infectious diseases like group B streptococcus. Well-timed diagnosis and treatment will prevent premature delivery and reduce the overall healthcare costs. Noninvasive prenatal diagnostics procedures are preferred over invasive procedures as it is a safe way to determine the health of the fetus without harming either the mother or the fetus.  The noninvasive prenatal diagnostics market is growing as a result of...
Lighting Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Lighting equipment could be mundanely understood as the equipment responsible for the production of light energy. With an ever increasing rise in the global population, and the rising awareness amongst us to protect our mother earth, lighting equipment market is experiencing a healthy growth rate. Rising global population, rising urbanization rate, invention of innovative products such as LED, rising go green initiatives, are some of the drivers of the lighting equipment market. The rising economies of the Asia Pacific countries, will serve as an opportunity for the lighting...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...